BioXell announces change in management
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Milan, Italy, 7 September 2009 - BioXell S.p.A. (SIX: BXLN) announcedtoday the termination on the basis of a mutual agreement of theemployment relationship with Bertrand Lehuu, Chief Business Officer,effective today. His responsibilities will be taken over by thecompany's Chief Executive Officer, Niels Ackermann."I would like to thank Bertrand Lehuu for his contribution during hisyears at BioXell as a member of the Management Team," said NielsAckermann, CEO of BioXell. "We wish him all the best for his futurecareer."About BioXellBioXell S.p.A. (SIX: BXLN) is a listed biopharmaceutical companyfocused on the discovery and development of drugs that exploit novelmechanisms of action. The Company is currently focusing its effortson the development of its monoclonal antibody BXL1H5 for thetreatment of chronic pain. Following the conclusion of its Vitamin D3related R&D activities BioXell is looking into a number of strategicoptions in line with the demands of its shareholders.BioXell was founded in 2002 as a spin-out from Roche. In June 2006,BioXell listed its shares on the main segment of the SIX SwissExchange. The Company is located in Milan, Italy.More information on BioXell can be found at: www.bioxell.comFor further information, please contact:BioXellS.p.A.Dynamics Group SAAlviseSagramosoChristophe LampsTel: +39 02 210 4951Tel: +41 (0)22 308 62 22Fax: +39 02 210 49529Fax: +41 (0)22 308 62 36alvise.sagramoso(at)bioxell.com cla(at)dynamicsgroup.chThis press release can be downloaded at www.bioxell.com.DisclaimerThis press release does not constitute or form part, or all, of anyoffer or invitation to sell or issue, or any solicitation of anyoffer to purchase or subscribe for, any securities, nor shall part,or all, of these materials or their distribution form the basis of,or be relied on in connection with, any contract or investmentdecision in relation to any securities. This press release containsforward-looking statements based on the currently held beliefs andassumptions of the management of BioXell, which are expressed in goodfaith and, in their opinion, reasonable. Forward-looking statementsinvolve known and unknown risks, uncertainties and other factors,which may cause the actual results, financial condition, performance,or achievements of BioXell, or industry results, to differ materiallyfrom the results, financial condition, performance or achievementsexpressed or implied by such forward-looking statements. Given theserisks, uncertainties and other factors, recipients of this documentare cautioned not to place undue reliance on these forward-lookingstatements. BioXell disclaims any obligation to update theseforward-looking statements to reflect future events or developments.http://hugin.info/133681/R/1339952/320096.pdf --- End of Message ---bioXell S.p.Avia Olgettina 58 Milan ItalyWKN: A0J3MW; ISIN: IT0004069933 ; Listed: Main Market in SIX Swiss Exchange;
Datum: 07.09.2009 - 20:00 Uhr
Sprache: Deutsch
News-ID 5561
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 486 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioXell announces change in management"
steht unter der journalistisch-redaktionellen Verantwortung von
bioXell S.p.A (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
